| Literature DB >> 35884964 |
Sheng-Fen Wang1, Tsung-Ting Tsai2, Yun-Da Li2, Ping-Yeh Chiu2, Ming-Kai Hsieh2, Jen-Chung Liao2, Po-Liang Lai2, Fu-Cheng Kao2,3.
Abstract
Background: Postoperative immunosuppression is associated with blood loss and surgical trauma during surgery and subsequently predisposes patients to increased morbidity. Spine endoscopic surgery has been accepted as an effective surgical technique with less surgical trauma and less blood loss for the complication of infectious spondylodiscitis. Therefore, the aim of this study was to investigate whether PEIDF could reduce the morbidity rates for patients with infectious spondylodiscitis.Entities:
Keywords: endoscopy; infectious spondylodiscitis; qSOFA; sepsis
Year: 2022 PMID: 35884964 PMCID: PMC9312856 DOI: 10.3390/biomedicines10071659
Source DB: PubMed Journal: Biomedicines ISSN: 2227-9059
Figure 1An 81-year-old female had the comorbidity of chronic kidney disease, stage 4, caused by poor-controlled diabetes mellitus, hypertension with atrial fibrillation, and ovarian cancer history, suffering from infectious spondylodiscitis complicated with severe endplate destruction and psoas muscle abscess (A). We performed PEIDF composed of percutaneous endoscopic debridement (B) and allogenous bone grafting (C) through the working sheath and posterior percutaneous pedicle screw fixation at one level above and below under the guidance of fluoroscopy (D).
Figure 2Flowchart of 2014–2019 cohort sample. ASA PS: American Society of Anesthesiologists physical status; CRP: C–reactive protein; PEIDF: percutaneous endoscopic interbody debridement and fusion.
Demographics and clinical data.
| PEIDF | Open | ||
|---|---|---|---|
| Number of patients | 15 | 29 | |
| Age (year) | 68.93 ± 14.09 | 70.83 ± 7.96 | 0.635 |
| Sex (Male/Female) | 8/7 | 12/17 | 0.450 |
| Comorbidity | |||
| Diabetic Mellitus | 5 | 13 | 0.462 |
| ESRD | 3 | 14 | 0.092 |
| COPD | 5 | 8 | 0.692 |
| Malignancy history | 3 | 4 | 0.594 |
| Pyogenic burden | |||
| Psoas abscess | 8 | 11 | 0.328 |
| Epidural abscess | 2 | 10 | 0.135 |
| Surgical data | |||
| Surgical time (minute) | 120.80 ± 25.79 | 128.49 ± 39.95 | 0.506 |
| Blood loss (mL) | <50 | 662.07 ± 489.47 | <0.001 * |
| Intraoperative transfusion | 0 | 16 | <0.001 * |
| Preoperative laboratory data | |||
| Albumin (g/dL) | 2.89 ± 0.73 | 3.14 ± 0.78 | 0.345 |
| CRP (mg/L) | 137.31 ± 78.21 | 140.66 ± 69.87 | 0.885 |
| WBC count (1000/μL) | 9.85 ± 2.95 | 12.49 ± 6.27 | 0.065 |
| Segment (%) | 75.47 ± 9.02 | 78.55 ± 9.89 | 0.320 |
| Platelet (1000/μL) | 257.33 ± 126.34 | 310.10 ± 162.97 | 0.280 |
| Hemoglobin (g/dL) | 9.85 ± 1.07 | 9.27 ± 1.76 | 0.177 |
| Postoperative laboratory data | |||
| CRP (mg/L) | 17.87 ± 19.96 | 41.73 ± 8.13 | 0.017 * |
| WBC count (1000/μL) | 6.67 ± 2.56 | 7.12 ± 2.17 | 0.451 |
| Segment (%) | 61.13 ± 8.04 | 62.47 ± 10.39 | 0.665 |
| Platelet (1000/μL) | 266.20 ± 63.59 | 263.13 ± 82.41 | 0.901 |
| D1 Hemoglobin (g/dL) | 9.81 ± 1.22 | 9.03 ± 1.27 | 0.059 |
| Culture rate (%) | 12 (80.0%) | 18 (62.1%) | 0.226 |
| Revision within one month | 0 | 5 | 0.135 |
| VAS score | |||
| Preoperative | 7.87 ± 1.06 | 7.66 ± 1.289 | 0.588 |
| Postoperative one week | 2.73 ± 0.704 | 4.52 ± 1.661 | <0.001 * |
ESRD, end-stage renal disease; COPD, chronic obstructive pulmonary disease; CRP, C-reactive protein; WBC, white blood cell; D1 Hemoglobin, hemoglobin on postoperative day 1; VAS, Visual Analogue Scale; *: p < 0.05, statistical significance.
Outcome assessment.
| PEIDF | Open | ||
|---|---|---|---|
| Sepsis (%) | 1 (6.7) | 11 (37.9) | 0.030 * |
| qSOFA ≥ 2 (%) | 0 (0.0) | 7 (24.1) | 0.044 * |
| Death (%) | 1 (6.7) | 3 (10.3) | 0.205 |
| Days to normal CRP level | 26.93 ± 11.55 | 41.31 ± 12.32 | 0.001 * |
qSOFA: quick sequential organ failure assessment. *: p < 0.05, statistical significance.
Figure 3The Kaplan–Meier curve shows that patients receiving conventional open surgery had a higher rate of sepsis within one month after surgery.
Figure 4The Kaplan–Meier curve shows that patients receiving conventional open surgery had a higher rate of a qSOFA of ≥2 within one month after surgery.
Figure 5The Kaplan–Meier survival curve demonstrates the postoperative mortality within one month between the two groups.